Display options
Cite
Bonneterre V, Bicout DJ, de Gaudemaris R. Application of pharmacovigilance methods in occupational health surveillance: comparison of seven disproportionality metrics. Saf Health Work. 2012;3(2):92-100doi: 10.5491/SHAW.2012.3.2.92.
Bonneterre, V., Bicout, D. J., & de Gaudemaris, R. (2012). Application of pharmacovigilance methods in occupational health surveillance: comparison of seven disproportionality metrics. Safety and health at work, 3(2), 92-100. https://doi.org/10.5491/SHAW.2012.3.2.92
Bonneterre, Vincent, et al. "Application of pharmacovigilance methods in occupational health surveillance: comparison of seven disproportionality metrics." Safety and health at work vol. 3,2 (2012): 92-100. doi: https://doi.org/10.5491/SHAW.2012.3.2.92
Bonneterre V, Bicout DJ, de Gaudemaris R. Application of pharmacovigilance methods in occupational health surveillance: comparison of seven disproportionality metrics. Saf Health Work. 2012 Jun;3(2):92-100. doi: 10.5491/SHAW.2012.3.2.92. Epub 2012 Jun 08. PMID: 22993712; PMCID: PMC3440466.
Copy Download .nbib Format: NLM
Share it on

Saf Health Work. 2012 Jun;3(2):92-100. doi: 10.5491/SHAW.2012.3.2.92. Epub 2012 Jun 08.

Application of pharmacovigilance methods in occupational health surveillance: comparison of seven disproportionality metrics.

Safety and health at work

Vincent Bonneterre, Dominique Joseph Bicout, Regis de Gaudemaris

Affiliations

  1. UJF-Grenoble 1/CNRS/TIMC-IMAG UMR 5525 (EPSP team- Environment and Health Prediction in Populations), Grenoble, France. ; Occupational and Environmental Diseases Centre, Grenoble Teaching Hospital (CHU Grenoble), Grenoble, France. ; The French National Occupational Diseases Surveillance and Prevention Network (RNV3P), France.

PMID: 22993712 PMCID: PMC3440466 DOI: 10.5491/SHAW.2012.3.2.92

Abstract

OBJECTIVES: The French National Occupational Diseases Surveillance and Prevention Network (RNV3P) is a French network of occupational disease specialists, which collects, in standardised coded reports, all cases where a physician of any specialty, referred a patient to a university occupational disease centre, to establish the relation between the disease observed and occupational exposures, independently of statutory considerations related to compensation. The objective is to compare the relevance of disproportionality measures, widely used in pharmacovigilance, for the detection of potentially new disease × exposure associations in RNV3P database (by analogy with the detection of potentially new health event × drug associations in the spontaneous reporting databases from pharmacovigilance).

METHODS: 2001-2009 data from RNV3P are used (81,132 observations leading to 11,627 disease × exposure associations). The structure of RNV3P database is compared with the ones of pharmacovigilance databases. Seven disproportionality metrics are tested and their results, notably in terms of ranking the disease × exposure associations, are compared.

RESULTS: RNV3P and pharmacovigilance databases showed similar structure. Frequentist methods (proportional reporting ratio [PRR], reporting odds ratio [ROR]) and a Bayesian one (known as BCPNN for "Bayesian Confidence Propagation Neural Network") show a rather similar behaviour on our data, conversely to other methods (as Poisson). Finally the PRR method was chosen, because more complex methods did not show a greater value with the RNV3P data. Accordingly, a procedure for detecting signals with PRR method, automatic triage for exclusion of associations already known, and then investigating these signals is suggested.

CONCLUSION: This procedure may be seen as a first step of hypothesis generation before launching epidemiological and/or experimental studies.

Keywords: Data mining; Occupational diseases; Occupational diseases network or database; Pharmacovigilance methods

References

  1. Sante Publique. 2008 May-Jun;20 Suppl 3:S201-10 - PubMed
  2. MMWR Suppl. 2004 Sep 24;53:28-31 - PubMed
  3. Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):604-10 - PubMed
  4. Eur J Clin Pharmacol. 2004 Dec;60(10):747-50 - PubMed
  5. Occup Environ Med. 2010 Aug;67(8):574-6 - PubMed
  6. Occup Med (Lond). 2011 Jan;61(1):33-9 - PubMed
  7. J Biomed Inform. 2011 Aug;44(4):545-52 - PubMed
  8. Drug Discov Today. 2009 Apr;14(7-8):343-57 - PubMed
  9. Br J Clin Pharmacol. 2004 Feb;57(2):127-34 - PubMed
  10. Epidemiology. 2010 May;21(3):376-8 - PubMed
  11. Drug Saf. 2002;25(6):381-92 - PubMed
  12. Occup Environ Med. 2008 Jan;65(1):32-7 - PubMed
  13. IEEE Trans Inf Technol Biomed. 2005 Dec;9(4):518-27 - PubMed
  14. Occup Environ Med. 2010 Mar;67(3):178-86 - PubMed
  15. Pharmacoepidemiol Drug Saf. 1999 Apr;8 Suppl 1:S15-25 - PubMed
  16. Occup Med (Lond). 2010 Jun;60(4):294-300 - PubMed
  17. MMWR Suppl. 2004 Sep 24;53:5-11 - PubMed
  18. Pharmacoepidemiol Drug Saf. 2002 Jan-Feb;11(1):3-10 - PubMed

Publication Types